Below you will find the clinical studies on Proactol™ patented ingredient (NeOpuntia®) and its fat binding properties.

Proactol Clinical Data:

TNO Report Part-1 2001 – Fat binding capacity of NeOpuntia® during passage through a dynamic gastrointestinal model.

http://www.proactol-reviews.com/pdf/TNO-2001-part1.pdf

TNO Report Part-2 2004 – Fat binding capacity of xxx during passage through a dynamic gastrointestinal model.

http://www.proactol-reviews.com/pdf/TNO-2004-part2.pdf

TNO Report Part-3 2005 – Fat binding capacity of NeOpuntia® in an American breakfast meal during passage through a dynamic gastrointestinal model.

http://www.proactol-reviews.com/pdf/TNO-2005-part3.pdf

Report Part-4 – Pilot Clinical Study of NeOpuntia® on Fat Binding

http://www.proactol-reviews.com/pdf/AG-Com(latest)part4.pdf

Here is a break down of each study:

Stay tuned for the upcoming launch of the official website and for more information on Proactol.